Saggy Breasts After Mounjaro or Ozempic: Your Surgical Options

Medically reviewed by Mr Debashis Ghosh, Consultant Breast and Cosmetic Surgeon, Harley Street Breast Centre. GMC: 4657664. FRCS, BAAPS, BAPRAS. Last reviewed: June 2026.
Quick answer
GLP-1 weight loss drugs such as Mounjaro, Ozempic and Wegovy cause breast tissue to reduce in volume and the overlying skin to become loose or saggy, especially when weight loss has been rapid. The surgical solutions depend on the specific problem: a breast lift (mastopexy) for sagging and ptosis, implants or fat transfer for volume loss or a combination of both – most surgeons advise stabilising your weight before operating.
Key takeaways
- GLP-1 drugs reduce adipose (fatty) breast tissue, causing upper pole flattening, sagging and loss of projection.
- Breast sagging is graded on the Regnault scale from Grade 1 (mild) to Grade 3 (severe) and this guides the surgical approach.
- A mastopexy (breast lift) repositions the nipple-areola complex and removes excess skin but does not restore volume.
- If volume loss is the primary concern, implants or fat transfer are the more appropriate option, sometimes combined with a lift.
- Weight should be stable for a minimum of 3-6 months before any breast surgery is performed.
- All cosmetic breast surgery carries risks including scarring, asymmetry, change in nipple sensation and the need for revision.
On this page
- Why do Mounjaro and Ozempic cause saggy breasts?
- How quickly does breast sagging develop on Mounjaro or Ozempic?
- What are the grades of breast sagging (ptosis)?
- What surgical options are available for GLP-1 breast changes?
- Implant-based restoration versus a breast lift: which is right for you?
- How long should you wait before having surgery?
- Risks and realistic expectations
- Frequently asked questions
- Sources
Why do Mounjaro and Ozempic cause saggy breasts?
The breast is made up of glandular tissue, adipose (fatty) tissue, Cooper’s ligaments and overlying skin. When significant weight loss occurs (whether from diet, exercise or medication) the fatty component of the breast reduces. GLP-1 receptor agonists such as Mounjaro (tirzepatide), Ozempic (semaglutide) and Wegovy (semaglutide) are among the most effective weight loss agents currently available, with clinical trials showing average body weight reductions of between 15 and 22% over 72 weeks – this is a substantial loss and for many women a significant proportion of it comes from the breasts.
The problem is that the skin envelope does not always keep pace with the loss of underlying volume. Skin has a degree of elasticity, but this varies considerably between individuals and is affected by age, genetics, sun exposure and the speed of weight loss. When rapid volume reduction occurs, the skin is left with more surface area than the tissue beneath it can fill. The result is sagging, wrinkling or a deflated appearance.
The Cooper’s ligaments (fibrous bands that support and suspend the breast tissues) also lose their tension as the fatty tissue they anchor into reduces – this allows the breast to descend, with the nipple and areola moving downward relative to the inframammary fold – the crease at the base of the breast …. this is the clinical definition of breast ptosis and it is the central problem for women who experience breast changes after GLP-1 medication.
How quickly does breast sagging develop on Mounjaro or Ozempic?
There is no fixed timeline – it depends on the amount of weight lost, the rate of loss, the individual’s skin quality, starting breast size and age. What we observe consistently in clinic is that women who lose 15% or more of their body weight, particularly those who do so within 6-12 months, are most likely to notice significant breast changes. Smaller losses, particularly in women with naturally denser, less fatty breast tissue, tend to produce fewer visible changes.
Rapid weight loss is more damaging to skin elasticity than gradual loss – the skin has more time to adapt when weight reduces slowly. Women who have previously been pregnant, breastfed or carried significant excess weight are particularly likely to see changes, because their skin and Cooper’s ligaments have been stretched before.
What patients commonly get wrong …. is assuming that the breast change will reverse if they regain some weight. In our experience, it often doesn’t. The sagging is a structural problem with the skin envelope and the ligaments – it is not simply a matter of refilling a container – putting weight back on may restore some volume but it does not re-tighten the skin or repair the ligaments.
What are the grades of breast sagging (ptosis)?
Breast ptosis is classified on the Regnault scale, which surgeons use to guide the choice of surgical technique. The classification is based on where the nipple sits relative to the inframammary fold:
| Grade | Clinical Description | Typical Surgical Approach |
|---|---|---|
| Grade 1 (Mild) | Nipple at or just below the inframammary fold. Minimal sagging. | Crescent or periareolar lift or augmentation alone. |
| Grade 2 (Moderate) | Nipple below the inframammary fold but above the lowest breast contour. | Vertical (lollipop) or anchor mastopexy, with or without implant. |
| Grade 3 (Severe) | Nipple well below the inframammary fold, pointing downward. | Anchor mastopexy, frequently combined with augmentation. |
| Pseudoptosis | Nipple position normal but significant lower breast tissue deflation. | Augmentation with or without a minimal lift. |
In practice, many women presenting with GLP-1-related breast changes have a combination of ptosis and volume loss – the grade of ptosis determines how much skin needs to be removed and where the new nipple-areola position should be and volume deficit is assessed separately.
What surgical options are available for GLP-1 breast changes?
The options broadly fall into 3 categories, each addressing a different aspect of the problem:
Mastopexy (breast lift)
A mastopexy reshapes and lifts the breast by removing excess skin and repositioning the nipple-areola complex to a more anatomically appropriate position however, it doesn’t add volume. If the primary issue is sagging or descent of the nipple with reasonable breast fullness remaining, a lift alone may be all that is needed.
Breast augmentation
Where volume loss is the primary concern and the nipple position is acceptable, breast augmentation using implants or fat transfer can restore projection and upper pole fullness. This is the right choice for women with pseudoptosis or Grade 1 ptosis who want a fuller result without scars on the breast itself.
Augmentation-mastopexy
This combines a lift with volume restoration and is the most common approach for women with both sagging and significant volume loss after GLP-1 medication. It is a more complex procedure than either alone and requires careful planning. The lift and augmentation must be designed together to avoid asymmetry or distortion of the nipple.
Fat transfer
For women who want a modest volume increase and have sufficient donor fat, lipofilling can be performed at the same time as a lift. It avoids the need for implants but cannot produce the degree of volume increase that implants can. The results are also less predictable, as not all transferred fat survives.
The single most important thing I tell patients at this point is not to rush. Weight loss on GLP-1 medication can continue for 12 months or longer and surgery performed on a body that is still changing will not give you a stable result. Come to clinic once your weight has been stable for at least 3-6 months and we can plan properly.
Mr Debashis Ghosh, Consultant Breast and Cosmetic Surgeon
Implant-based restoration versus a breast lift: which is right for you?
This is the question we are asked most often at consultation – the answer depends entirely on your anatomy and your goals:-
| Factor | Lift Only | Implants Only | Combined (Aug-Mastopexy) |
|---|---|---|---|
| Best for | Adequate volume, significant sagging | Volume loss, minimal sagging | Both volume loss and sagging |
| Scarring | Lollipop or anchor pattern | Small incisions only | Lollipop or anchor pattern |
| Volume change | None | Significant increase | Tailored to anatomy |
| Recovery | 2-3 weeks | 2-3 weeks | 3-4 weeks |
| Complexity | Moderate | Moderate | Higher – requires careful planning |
What I explain to patients who come to me after GLP-1 weight loss is that an implant placed into a breast with significant sagging will not lift the nipple – it will simply make the breast larger and lower. Conversely, a lift alone will correct position but will not replace lost volume or projection. The assessment at consultation determines which combination, if any, is appropriate for your specific anatomy.
How long should you wait before having surgery?
Weight stability is the critical factor – operating on a patient whose weight is still changing introduces significant risk to the result – if you lose further weight after a lift the breast may sag again and if you gain weight an augmentation result may change considerably.
The standard advice from BAAPS and BAPRAS is to wait until your weight has been stable for a minimum of 3-6 months. For women who are still on GLP-1 medication, this usually means waiting until the medication-driven weight loss has stabilised.
There is no advantage to operating early – the risks are higher and the likelihood of needing a revision procedure increases. We would rather see someone who has been patient with their recovery and arrives at clinic with a stable body than one who rushes into surgery while still losing weight.
Risks and realistic expectations
All cosmetic breast surgery carries surgical risk. The risks specific to mastopexy and augmentation include:
- Scarring: all lifts require incisions on the breast. Scars fade over 12-24 months but are permanent. The pattern varies by technique (periareolar, vertical/lollipop or anchor/inverted-T). Scar quality varies between individuals.
- Asymmetry: no 2 breasts are identical before or after surgery. Minor asymmetry is normal however, significant asymmetry may require a secondary procedure.
- Change in nipple or breast sensation: this is common in the months following surgery and usually temporary, but some change in sensation may be permanent.
- Implant complications (for augmentation): implant-related complications include capsular contracture, implant rupture, rippling and the rare but serious risk of breast implant-associated ALCL. All patients receive full information on MHRA guidance regarding breast implant safety at consultation.
- Need for revision: the breast changes with age, weight and hormonal shifts. Revision surgery may be required over time.
- General surgical risks: infection, haematoma, deep vein thrombosis and anaesthetic complications apply to any surgical procedure.
Choosing a surgeon who is a member of BAAPS or BAPRAS and operates exclusively in CQC-registered hospitals is an important step in minimising risk. Mr Ghosh operates from The London Clinic, The Harley Street Clinic and the Royal Free London.
Book a consultation with Mr Ghosh
If you have noticed changes to your breasts on Mounjaro, Ozempic or Wegovy, a private consultation is the starting point. Mr Ghosh will assess your anatomy, grade your ptosis, discuss volume and establish what surgery, if any, is appropriate for your goals. Book a free 10-minute discovery call or a paid in-person consultation at the clinic.
Frequently asked questions
Will my breasts go back to normal if I stop taking Mounjaro or Ozempic?
For most women the answer is partially. Some volume may return if weight is regained, but structural changes to the skin envelope and Cooper’s ligaments are unlikely to reverse on their own. The extent of recovery depends on the degree of sagging, individual skin quality and age.
Can I have a breast lift and augmentation at the same time?
Yes. Combined augmentation-mastopexy is performed as a single-stage procedure in most cases. It requires more careful surgical planning than either procedure alone because the two techniques must work together rather than against each other. In some cases, particularly those involving significant asymmetry or poor skin quality, a staged approach is safer.
How long does mastopexy surgery take?
A straightforward lift takes approximately two to two and a half hours under general anaesthesia. A combined augmentation-mastopexy typically takes between two and a half and 4 hours depending on the degree of ptosis and the implant size.
What is the recovery like after a breast lift?
Most patients are comfortable at home within a few days, wearing a supportive bra throughout. Swelling and bruising resolve over 2-4 weeks. Return to sedentary work is usually possible within 1-2 weeks and strenuous activity after 6 weeks. Final results take 3-6 months to fully settle as swelling subsides and scars mature.
Will I have scars after a breast lift?
All mastopexy techniques involve incisions and permanent scars. The pattern depends on the degree of sagging being corrected. A minor lift may leave only a scar around the areola. Moderate to severe ptosis typically requires a vertical scar down the lower breast (lollipop) or a combination of vertical and horizontal scars (anchor). Scars are initially pink and may be slightly raised, but fade significantly over 12-24 months.
Can Mounjaro breast sagging be fixed without surgery?
Non-surgical skin tightening devices, such as radiofrequency or ultrasound energy treatments, can improve mild skin laxity but are not effective for treating structural breast ptosis. If the nipple has descended significantly or there is substantial excess skin, only surgery can reliably correct this.
How much does breast lift surgery cost in London?
Private breast lift surgery in London typically costs between £6,000 and £12,000 depending on the technique required, whether augmentation is included and surgeon experience. All consultations with Mr Ghosh include an all-inclusive quote with no hidden costs. The quote covers the surgical fee, anaesthesia, facility fee and standard aftercare.
When is the right time to consider surgery after GLP-1 weight loss?
Surgery should be considered once your weight has been stable for a minimum of 3-6 months and you are confident you do not intend to lose significantly more weight. Most surgeons also recommend that your BMI be within a healthy range before elective breast surgery is performed.
Will a breast lift affect breastfeeding in future?
A mastopexy can affect breastfeeding ability. The extent depends on the technique used and how much glandular tissue and ductal connections are disrupted. If future breastfeeding is a consideration, this must be discussed at consultation so the surgical plan can take it into account where possible.
Do I need a GP referral to see Mr Ghosh for a breast consultation?
No. You can self-refer directly to Harley Street Breast Centre without a GP referral. The clinic accepts self-funded patients and those with private medical insurance. Insurance patients should check their policy for cosmetic exclusions.
Sources
British Association of Aesthetic Plastic Surgeons (BAAPS): baaps.org.uk
British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS): bapras.org.uk
MHRA breast implant safety information: gov.uk/guidance/breast-implants
Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021.
Medical disclaimer
This article is for informational purposes only and does not constitute medical advice. Individual surgical results vary. The risks and benefits of any procedure should be discussed in full at a private consultation with a qualified surgeon. ASA/CAP guidance applies to all information relating to cosmetic surgery. Surgery is not suitable for everyone.
About Mr Debashis Ghosh
Mr Debashis Ghosh is a Consultant Breast and Cosmetic Surgeon practising at Harley Street Breast Centre, 146 Harley Street, London W1G 7LD.
He holds full fellowship of the Royal College of Surgeons (FRCS) and is a member of both BAAPS and BAPRAS.
He operates exclusively from The London Clinic, The Harley Street Clinic and the Royal Free London, providing care for both cosmetic and oncoplastic breast surgery. GMC: 4657664.
If saggy breasts after Mounjaro is affecting how you feel about your body, the next step is an assessment with a BAAPS and BAPRAS registered surgeon. Mr Debashis Ghosh, Consultant Breast and Cosmetic Surgeon at the Harley Street Breast Centre, 146 Harley Street, London, will examine you, grade the changes and set out which options are realistic for your anatomy.
Book your consultation
Harley Street Breast Centre, 146 Harley Street, London W1G 7LD
Call: +44 (0) 207 034 6534
Free discovery call available or in-clinic paid initial consultations.
Wondering what this means for you?
Start with a free telephone consultation from home, or meet Mr Ghosh in person on Harley Street. Ask anything, decide nothing until you are ready.
Book a Consultation